In: Managing Contraception 2016 Limited Edition | Overview of the use of combined estrogen-progestin oral contraceptives |
---|---|
: Afaxys Pharma LLC; 2018 | Collaborative Group on Hormonal Factors in Breast Cancer |
Oral contraceptive use and risk of breast cancer | |
---|---|
Patient education: Emergency contraception morning after pill Beyond the Basics | Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies |